David Larsen
Stock Analyst at BTIG
(2.05)
# 2,901
Out of 4,876 analysts
74
Total ratings
34.48%
Success rate
-2.01%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Upgrades: Buy | $80 | $61.18 | +30.76% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $21.71 | +28.97% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $49.32 | -29.03% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $105.53 | +23.19% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $23.10 | +34.20% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $158.31 | +64.23% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $17.34 | +188.43% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $23.43 | -14.64% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $24.82 | +182.03% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $3.79 | +84.70% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $284.47 | -15.63% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.67 | +320.42% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $13.37 | +4.71% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.16 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.22 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $10.77 | +317.83% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.86 | +444.04% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.28 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.99 | +59.16% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.71 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $7.32 | +1,197.81% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.88 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $167.35 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $729.00 | -78.05% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.42 | +513.23% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.68 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $68.46 | +24.16% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $8.42 | +173.32% | 1 | Nov 2, 2017 |
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $61.18
Upside: +30.76%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $21.71
Upside: +28.97%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $49.32
Upside: -29.03%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $105.53
Upside: +23.19%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $23.10
Upside: +34.20%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $158.31
Upside: +64.23%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $17.34
Upside: +188.43%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $23.43
Upside: -14.64%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $24.82
Upside: +182.03%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.79
Upside: +84.70%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $284.47
Upside: -15.63%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.67
Upside: +320.42%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $13.37
Upside: +4.71%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.16
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $29.22
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $10.77
Upside: +317.83%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.86
Upside: +444.04%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.28
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.99
Upside: +59.16%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.71
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $7.32
Upside: +1,197.81%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.88
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $167.35
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $729.00
Upside: -78.05%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.42
Upside: +513.23%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.68
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $68.46
Upside: +24.16%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $8.42
Upside: +173.32%